These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 37280384

  • 1. Preoperative BChE serves as a prognostic marker in patients with resectable AEG after neoadjuvant chemotherapy.
    Gensthaler L, Jomrich G, Brugger J, Kollmann D, Paireder M, Bologheanu M, Horn A, Riegler FM, Asari R, Schoppmann SF.
    Langenbecks Arch Surg; 2023 Jun 06; 408(1):227. PubMed ID: 37280384
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical implications of Naples prognostic scores in patients with resectable Siewert type II-III adenocarcinoma of the esophagogastric junction].
    Jin P, Ma G, Liu Y, Ke B, Liu HM, Liang H, Zhang RP.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Jan 25; 27(1):54-62. PubMed ID: 38262901
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z, Wang Y, Li F, Gao J, Han B, Wang R, Xue Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):149-155. PubMed ID: 30799537
    [Abstract] [Full Text] [Related]

  • 7. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y, Wang Q, Wang J, Qiao XY, Zhang J, Lin YC, Li Y, Fan LQ, Yang PG, Zhao Q.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb 25; 24(2):128-137. PubMed ID: 33508918
    [Abstract] [Full Text] [Related]

  • 8. Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy.
    Koie T, Ohyama C, Hatakeyama S, Imai A, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Hosogoe S, Yamamoto H, Kitayama M, Hirota K.
    Int J Clin Oncol; 2016 Apr 25; 21(2):379-383. PubMed ID: 26223693
    [Abstract] [Full Text] [Related]

  • 9. High Mean Corpuscular Volume Predicts Poor Outcome for Patients With Gastroesophageal Adenocarcinoma.
    Jomrich G, Hollenstein M, John M, Ristl R, Paireder M, Kristo I, Asari R, Schoppmann SF.
    Ann Surg Oncol; 2019 Apr 25; 26(4):976-985. PubMed ID: 30706229
    [Abstract] [Full Text] [Related]

  • 10. A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients.
    Blank S, Rachakonda S, Keller G, Weichert W, Lordick F, Langer R, Springfeld C, Bruckner T, Becker K, Kumar R, Ott K.
    BMC Cancer; 2014 Feb 03; 14():58. PubMed ID: 24490800
    [Abstract] [Full Text] [Related]

  • 11. Butyrylcholinesterase level as an independent prognostic factor for overall survival in patients on maintenance hemodialysis: a single-center retrospective study.
    Fukushi K, Okamoto T, Ozaki Y, Ozaki K, Sasaki D, Miura Y, Okuyama Y, Tanaka Y, Imanishi K, Hatakeyama S, Saitoh F, Ohyama C.
    Clin Exp Nephrol; 2022 Feb 03; 26(2):190-197. PubMed ID: 34581897
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The prognostic value of tumor-infiltrating lymphocytes in non-small cell lung cancer patients who received neoadjuvant chemotherapy followed by surgery.
    Hou Z, Zhao L, Zou L, Li B.
    Adv Clin Exp Med; 2023 Aug 03; 32(8):847-853. PubMed ID: 36881364
    [Abstract] [Full Text] [Related]

  • 14. The predictive role of hematologic markers in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy: a retrospective cohort study.
    Liu W, Ren S, Yang L, Xiao Y, Zeng C, Chen C, Wu F, Hu Y.
    Int J Surg; 2023 Nov 01; 109(11):3519-3526. PubMed ID: 37578441
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers treated with neoadjuvant chemotherapy.
    Yang X, Rao J, Yang W, Shui R.
    Target Oncol; 2018 Dec 01; 13(6):757-767. PubMed ID: 30406444
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.
    Kauppi JT, Oksala N, Salo JA, Helin H, Karhumäki L, Kemppainen J, Sihvo EI, Räsänen JV.
    Acta Oncol; 2012 May 01; 51(5):636-44. PubMed ID: 22208782
    [Abstract] [Full Text] [Related]

  • 18. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
    Thomaschewski M, Hummel R, Petrova E, Knief J, Wellner UF, Keck T, Bausch D.
    World J Gastroenterol; 2018 Apr 07; 24(13):1429-1439. PubMed ID: 29632424
    [Abstract] [Full Text] [Related]

  • 19. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):427-36. PubMed ID: 15380576
    [Abstract] [Full Text] [Related]

  • 20. Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma.
    Borg D, Larsson AH, Hedner C, Nodin B, Johnsson A, Jirström K.
    J Transl Med; 2018 Oct 24; 16(1):290. PubMed ID: 30355278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.